HMS Holdings Corp (NASDAQ:HMSY) Expected to Post Quarterly Sales of $171.48 Million

Brokerages expect that HMS Holdings Corp (NASDAQ:HMSY) will report sales of $171.48 million for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for HMS’s earnings, with the lowest sales estimate coming in at $170.10 million and the highest estimate coming in at $173.30 million. HMS reported sales of $155.83 million during the same quarter last year, which indicates a positive year-over-year growth rate of 10%. The company is expected to report its next quarterly earnings results on Friday, February 28th.

On average, analysts expect that HMS will report full-year sales of $634.06 million for the current fiscal year, with estimates ranging from $633.00 million to $635.00 million. For the next year, analysts anticipate that the company will post sales of $680.60 million, with estimates ranging from $668.11 million to $694.20 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that cover HMS.

HMS (NASDAQ:HMSY) last announced its quarterly earnings results on Friday, November 1st. The business services provider reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.02. HMS had a return on equity of 14.28% and a net margin of 16.69%. The business had revenue of $146.82 million during the quarter, compared to the consensus estimate of $165.79 million. During the same quarter last year, the firm posted $0.28 EPS. The company’s quarterly revenue was down 4.8% on a year-over-year basis.

HMSY has been the topic of several research analyst reports. ValuEngine lowered HMS from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. BidaskClub lowered HMS from a “hold” rating to a “sell” rating in a research note on Saturday, October 26th. Leerink Swann initiated coverage on HMS in a research note on Monday, August 5th. They issued an “outperform” rating and a $50.00 price objective on the stock. Cantor Fitzgerald set a $42.00 price objective on HMS and gave the company a “buy” rating in a research note on Friday, August 2nd. Finally, Zacks Investment Research raised HMS from a “hold” rating to a “strong-buy” rating and set a $29.00 price objective on the stock in a research note on Tuesday, November 5th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $40.76.

HMS stock traded up $0.39 during mid-day trading on Thursday, hitting $27.17. 590,200 shares of the company’s stock traded hands, compared to its average volume of 580,870. The firm has a 50 day simple moving average of $33.14 and a two-hundred day simple moving average of $33.52. The stock has a market cap of $2.37 billion, a price-to-earnings ratio of 32.35, a P/E/G ratio of 2.31 and a beta of 1.16. The company has a debt-to-equity ratio of 0.31, a current ratio of 6.68 and a quick ratio of 6.72. HMS has a fifty-two week low of $24.43 and a fifty-two week high of $40.67.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

In other news, Director Richard H. Stowe sold 2,766 shares of HMS stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $37.43, for a total transaction of $103,531.38. Following the sale, the director now directly owns 81,763 shares of the company’s stock, valued at $3,060,389.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jeffrey Scott Sherman sold 35,896 shares of HMS stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $38.83, for a total value of $1,393,841.68. Following the sale, the chief financial officer now directly owns 213,661 shares in the company, valued at $8,296,456.63. The disclosure for this sale can be found here. Insiders have sold 220,656 shares of company stock worth $8,376,626 over the last three months. Insiders own 2.87% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Point72 Hong Kong Ltd lifted its stake in shares of HMS by 162.5% in the second quarter. Point72 Hong Kong Ltd now owns 953 shares of the business services provider’s stock worth $31,000 after acquiring an additional 590 shares during the period. Steward Partners Investment Advisory LLC acquired a new position in shares of HMS in the second quarter worth approximately $35,000. Meeder Asset Management Inc. lifted its stake in shares of HMS by 456.7% in the third quarter. Meeder Asset Management Inc. now owns 1,197 shares of the business services provider’s stock worth $41,000 after acquiring an additional 982 shares during the period. Tower Research Capital LLC TRC bought a new stake in HMS in the third quarter worth approximately $103,000. Finally, FinTrust Capital Advisors LLC bought a new stake in HMS in the third quarter worth approximately $125,000. 96.50% of the stock is currently owned by hedge funds and other institutional investors.

About HMS

HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.

Recommended Story: What is the formula for the cash asset ratio?

Get a free copy of the Zacks research report on HMS (HMSY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HMS (NASDAQ:HMSY)

Leave a Reply

Your email address will not be published. Required fields are marked *

*